• / Free eNewsletters & Magazine
  • / My Account
Home>UPDATE: First-ever bio-generic drug doesn't help Novartis shares

UPDATE: First-ever bio-generic drug doesn't help Novartis shares

3party Content

Fri, 6 Mar 2015

By Russ Britt, MarketWatch Litigation could prevent chemotherapy drug out of U.S. markets Usually when a company makes history or sets a new precedent, there's at least a little pop in the stock. Not so with Novartis AG on Friday. Instead, shares of the Swiss drug maker (NVS) dropped more than 1%
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.